ArticlePediatric nephrology (Berlin, Germany)2026
Early detection of arteriovenous fistula problems among pediatric patients on hemodialysis.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArteriovenous fistula (AVF) dysfunction is a common complication in pediatric patients on hemodialysis (HD). Early detection using clinical, radiological, and biochemical markers is essential to preserve vascular access. This study evaluated the diagnostic value of physical examination, duplex ultrasonography (DUS), intradialytic hemodynamic parameters, and inflammatory biomarkers in detecting AVF dysfunction.
methodsThis prospective cohort study included 59 pediatric patients (< 18 years) with chronic kidney disease (CKD) stage 5 on maintenance HD via functioning AVF, followed for 12 months. Patients underwent serial clinical assessment, laboratory testing (hs-CRP, IL-10, TNF-α), and DUS evaluation. Intradialytic venous pressure (VP) and transmembrane pressure (TMP) were recorded, and AVF complications were analyzed.
resultsAVF complications occurred in 55.9% of patients, most commonly thrombosis (28.8%), aneurysm (23.7%), and stenosis (10.2%). Physical examination showed moderate sensitivity (66.7%), but high specificity (100%) compared with DUS. Elevated VP and TMP were early indicators of dysfunction, significantly increased prior to structural changes on DUS (p < 0.001). The hs-CRP and IL-10 increased significantly at complication onset and were specifically elevated in stenosis, while TNF-α showed only a non-significant trend. Aneurysm was linked to higher flow volume and diameter, whereas thrombosis was linked to reduced diameter and flow.
conclusionsAVF dysfunction is frequent in pediatric HD patients. DUS is superior to physical examination for early detection. Intradialytic VP and TMP are useful early markers of impending dysfunction. hs-CRP showed a potential value in identifying stenosis, while other inflammatory markers show limited utility. A combined surveillance approach using clinical assessment, DUS, and hemodynamic monitoring is recommended to improve AVF outcomes.
Indexed as
Identifiers
42608558What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.